Editorial from Biotech Daily, page-81

They are shorting a treat in the US. The stats you supply are for the ASX.

Plus MSB moves on low volumes on the ASX , so the shorting is comparatively high. The shorting along with negative Macbank reports has been ridiculous and sustained and defies rationality. IMO.

Plus I'm not an upramper. I am merely providing an alternative opinion. I provide a basis for that opinion which people can independently verify.

Downrampers often climb on board the fear bandwagon and like to stop rational discussion and an exchange of ideas which include the positive; such people don't want the likes of me on board.

They want a clear run. To do this they will resort to provocation, name calling, making slurs, making misrepresentations, misquoting, taking statements out of context deliberately refusing to understand a line of argument, ignoring sound factual points, cherry picking, mobbing, attempting to discredit...all of which I am not intimidated by.

I remain resolute about my right to post an alternative POV and remind others that if you sell to crystallise a loss, you better be sure that the company actually is a real dud and that you're not simply acting out of fear.

MSB is on the cusp of some colossal changes of gear, and is placed on the Nasdaq to take advantage of the positive anns when they come. Those anns would not have the same broad impact as in Australia which is a much smaller market and far less sophisticated than the US. Right now we are needing some anns to stem the tide, but it will swing back. The US market is not yet responding positively because some missing pieces are about to fall into place which the instos cannot ignore. Right now they are standing back and some are accumulating at bargain basement levels.

I make posts to attempt to balance the discussion and help people think rationally about what decisions they are taking.

Repeat: this is a discussion board, not an agreement board.

Let that sink in.